HOOKIPA Pharma Inc. (HOOK)

OTC Pharmaceutical Pharmaceutical Preparations SIC: 2834
D
Pipeline Grade

Financial Position (from SEC Filings)

$40.5M
Cash & Equivalents
$0.1M
Quarterly Burn Rate
$14M
Market Cap

Estimated from most recent SEC quarterly filing. View SEC filings

Drug Pipeline (0 Assets)

No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.

Upcoming Catalysts

DateEventDrug
2027-04-01 Phase1 Readout —

Active Clinical Trials (1)

NCT #TitlePhaseStatusEnrollment
NCT06373380 A Study of HB-202/HB-201 in People With Human Papilloma Virus 16-Positive Head and Neck Squamous Cell Cancer (HPV 16+ HN... PHASE1 Active Not Recruiting 7

Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.

More Analysis

AI Stock Score

SEC EDGAR fundamental analysis with Claude AI & ChatGPT ratings for HOOK.

SEC EDGAR Filings

All SEC filings for HOOKIPA Pharma Inc. on EDGAR.

Full Calendar

View all upcoming FDA catalysts across all biotech companies.